FI891478A0 - Foerening. - Google Patents

Foerening.

Info

Publication number
FI891478A0
FI891478A0 FI891478A FI891478A FI891478A0 FI 891478 A0 FI891478 A0 FI 891478A0 FI 891478 A FI891478 A FI 891478A FI 891478 A FI891478 A FI 891478A FI 891478 A0 FI891478 A0 FI 891478A0
Authority
FI
Finland
Prior art keywords
foerening
Prior art date
Application number
FI891478A
Other languages
English (en)
Other versions
FI891478A (fi
Inventor
Jan Ingemar Vogeler
Nils-Erik Lennart Andersson
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Publication of FI891478A0 publication Critical patent/FI891478A0/fi
Publication of FI891478A publication Critical patent/FI891478A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/10Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
FI891478A 1986-09-29 1989-03-28 Foerening. FI891478A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8604117A SE8604117D0 (sv) 1986-09-29 1986-09-29 Composition
PCT/SE1987/000419 WO1988002221A1 (en) 1986-09-29 1987-09-18 A granulate containing gamma linolenic acid, eicosapentaenoic acid and/or docosahexaenoic acid, the method for its manufacturing, its use in edible products, and a tablet containing it

Publications (2)

Publication Number Publication Date
FI891478A0 true FI891478A0 (fi) 1989-03-28
FI891478A FI891478A (fi) 1989-03-28

Family

ID=20365745

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891478A FI891478A (fi) 1986-09-29 1989-03-28 Foerening.

Country Status (6)

Country Link
EP (2) EP0266323A1 (fi)
AU (1) AU8028287A (fi)
DK (1) DK291988A (fi)
FI (1) FI891478A (fi)
SE (1) SE8604117D0 (fi)
WO (1) WO1988002221A1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718523D0 (en) * 1987-08-05 1987-09-09 Unilever Plc Marine/vegetable oil blend
GB2223943A (en) * 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
GB8923833D0 (en) * 1989-10-23 1989-12-13 Unilever Plc Dry solid compositions containing lipid
EP0424578A1 (en) * 1989-10-23 1991-05-02 Unilever N.V. Dry solid compositions containing lipid
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
EP1092352A3 (en) * 1991-01-24 2003-08-27 Martek Corporation Microbial oil mixtures and uses thereof
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
JP2558050B2 (ja) * 1993-02-18 1996-11-27 イセ食品株式会社 鶏用飼料
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
GB9419345D0 (en) * 1994-09-26 1994-11-09 Sandoz Nutrition Ltd Organic compounds
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
FR2737849B1 (fr) * 1995-08-18 1997-09-19 Boiron Complement nutritionnel absorbable pour l'equilibre quotidien des seniors
US6428832B2 (en) * 1996-03-26 2002-08-06 Dsm N.V. Late addition of PUFA in infant formula preparation process
DK2260716T3 (da) * 1996-03-26 2014-05-12 Dsm Ip Assets Bv Sen tilsætning af PUFA ved fremstillingsproces for formulering til spædbørn
ATE218278T1 (de) * 1996-03-26 2002-06-15 Dsm Nv Pulverförmige polyungesättigte fettsäure- zusammensetzung für nahrungsmittel
US6048557A (en) * 1996-03-26 2000-04-11 Dsm N.V. PUFA coated solid carrier particles for foodstuff
AU2893097A (en) * 1996-04-29 1997-11-19 Agricultural Academy Of Krakow Oral delivery form having a high absorption efficiency and method for making same
DE69728206T2 (de) * 1996-05-14 2005-03-10 Dsm Ip Assets B.V. Herstellungsverfahren für Carotenoid-Zusammensetzungen
CA2360418C (en) * 1999-01-12 2009-05-26 Steven William Booth Spheronised self-emulsifying system for hydrophobic and water-sensitive agents
GB9925997D0 (en) * 1999-11-04 2000-01-12 Vitaflo Limited A medical composition for the treatment and/or prevention of malnutrition
EP1155620B1 (en) * 2000-05-18 2005-08-10 Q-mega healthcare A/S Dietary supplement comprising vitamins, minerals and polyunsaturated fatty acids
GB0110408D0 (en) * 2001-04-27 2001-06-20 Smithkline Beecham Plc Composition
FI114894B (fi) * 2002-05-02 2005-01-31 Omecol Finland Oy Elintarvikekoostumus
FR2839887A1 (fr) 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
AU2003238743A1 (en) * 2002-05-30 2003-12-19 Granate Seed Limited Starch products involving a starch-lipid complex, their preparation and uses
US8617617B2 (en) * 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
EP1616486A1 (en) * 2004-07-13 2006-01-18 Friesland Brands B.V. Powdered compositions containing an edible oil and their use in food products
US20080279935A1 (en) * 2005-02-18 2008-11-13 Swg Invest As Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base
FR2882656B1 (fr) * 2005-03-07 2007-06-22 Schwartz Laboratoires Robert S Composition antitabagique
EP1969952A1 (en) * 2007-03-07 2008-09-17 Friesland Brands B.V. Allergen-free or dairy free LCPUFA powdered compositions and the use thereof in food products and especially infant formulas
WO2012153345A1 (en) 2011-04-28 2012-11-15 Duragkar Nandakishore Jeevanrao Docosahexaenoic acid (dha) as polyunsaturated free fatty acid in its directly compressible powder form and method of isolation thereof
ES2778084A1 (es) * 2019-02-07 2020-08-07 Casanueva Antonio Castano Composicion de tacos o pellets compactos ricos en grasas y procedimiento de fabricacion de los mismos sin vapor, utilizando como ligante las propiedades queratinizantes de la cascara de marisco
WO2023146984A1 (en) * 2022-01-26 2023-08-03 Amarin Pharmaceuticals Ireland Limited Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
US4242364A (en) * 1978-12-19 1980-12-30 R.G.B. Laboratories, Inc. Dry powdered non-dairy food composition containing liquid fat
EP0092076B1 (fr) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Composition lipidique destinée à l'alimentation orale, entérale ou parentérale
GB2140806B (en) * 1983-05-28 1987-10-28 Sekimoto Hiroshi Stabilisation of unsaturated fatty acids, fish oils or fish
AU4595985A (en) * 1984-08-10 1986-02-13 Sentrachem Limited Cancer treatment

Also Published As

Publication number Publication date
WO1988002221A1 (en) 1988-04-07
DK291988D0 (da) 1988-05-27
EP0324762A1 (en) 1989-07-26
AU8028287A (en) 1988-04-21
DK291988A (da) 1988-05-30
EP0266323A1 (en) 1988-05-04
SE8604117D0 (sv) 1986-09-29
FI891478A (fi) 1989-03-28

Similar Documents

Publication Publication Date Title
ATE70057T1 (de) Antitumormittel.
DE3775679D1 (de) Vernebler.
DE3767169D1 (de) Sportschuh.
ATE57924T1 (de) 3-aryloxy-3-substituierte-propanamine.
DE3764043D1 (de) Alkylendiamine.
FI891478A (fi) Foerening.
ATE63533T1 (de) Xylolisomerisierung.
DE3779761D1 (de) Abseilgeraet.
DE3771918D1 (de) Chinolinamide.
DE3785294D1 (de) Neigungsmesser.
DE3786679T2 (de) Schmitt-triggerschaltung.
DE3773636D1 (de) Saeurebeschleunigte hydrocarboxilierung.
DE3771271D1 (de) Fluorphthalimide.
FI860054A (fi) Motionsanordning.
DE3779382D1 (de) 3-6-diphenylpyridazine.
FI872099A0 (fi) Hoegelastisk axelkoppling.
DE3763648D1 (de) Rollski.
FI860046A0 (fi) Foerlaengningsanordning foer traefaner.
DE3766410D1 (de) Methylalkylcyclosiloxane.
DE3669032D1 (de) Okulopressionsgeraet.
DE3770459D1 (de) 3-halogensuccinimide.
DE3764485D1 (de) Polyglycidylamine.
FI873424A0 (fi) Kompressionstvaettare foer pappersmassa.
DE3781179T2 (de) Acyl-coa-synthetase.
FI851776L (fi) Elkandelaber.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: KABIVITRUM AB